- 74
- 52 704
OCT Clinical Trials
Latvia
เข้าร่วมเมื่อ 5 ก.ย. 2013
OCT is a leading CRO operating in Central and Eastern Europe and the CIS region. With a team of 150 professionals, OCT provides a full range of high-quality services in management of Phase I-IV and BE studies.
With local expertise and focus on quality, OCT ensures seamless clinical trial conduct and registration on time and within budget. Our experienced team delivers both standalone services such as medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development.
Since 2005, OCT has been working on more than 300 full-service and functional service projects in 29 therapeutic areas.
Contact us:
✉️ info@oct-clinicaltrials.com
✉️ USA: usa@oct-clinicaltrials.com
✉️ The Netherlands: netherlands@oct-clinicaltrials.com
Follow us:
🌐 Official website: www.oct-clinicaltrials.com/
With local expertise and focus on quality, OCT ensures seamless clinical trial conduct and registration on time and within budget. Our experienced team delivers both standalone services such as medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development.
Since 2005, OCT has been working on more than 300 full-service and functional service projects in 29 therapeutic areas.
Contact us:
✉️ info@oct-clinicaltrials.com
✉️ USA: usa@oct-clinicaltrials.com
✉️ The Netherlands: netherlands@oct-clinicaltrials.com
Follow us:
🌐 Official website: www.oct-clinicaltrials.com/
Why Use a Clinical Trial Management System?
Every clinical trial requires proper management and control, and every clinical trial coordinator knows that a well-working clinical trial management system (CTMS) is the key to success.
Ksenia Manankova, OCT’s Senior Clinical Trial Coordinator and Supervisor of CTMS, will give you enough reasons why using CTMS will benefit all the aspects of your trial.
Welcome the 4th episode of our CRO Insights series!
Enjoy and subscribe to our TH-cam channel to be the first to know about new content on clinical research.
Webpage: oct-clinicaltrials.com/.
Experience: oct-clinicaltrials.com/oct-expertise.
Blog, articles, case studies: oct-clinicaltrials.com/resources.
LinkedIn: www.linkedin.com/company/oct-clinical-trials-in-central-and-eastern-europe/
✉Reach out to become the next speaker: pr@oct-clinicaltrials.com
✉Submit an RFP for clinical services: info@oct-clinicaltrials.com
#cro #octclinical #ctms #clinicaltrialmanagementsystem
Ksenia Manankova, OCT’s Senior Clinical Trial Coordinator and Supervisor of CTMS, will give you enough reasons why using CTMS will benefit all the aspects of your trial.
Welcome the 4th episode of our CRO Insights series!
Enjoy and subscribe to our TH-cam channel to be the first to know about new content on clinical research.
Webpage: oct-clinicaltrials.com/.
Experience: oct-clinicaltrials.com/oct-expertise.
Blog, articles, case studies: oct-clinicaltrials.com/resources.
LinkedIn: www.linkedin.com/company/oct-clinical-trials-in-central-and-eastern-europe/
✉Reach out to become the next speaker: pr@oct-clinicaltrials.com
✉Submit an RFP for clinical services: info@oct-clinicaltrials.com
#cro #octclinical #ctms #clinicaltrialmanagementsystem
มุมมอง: 305
วีดีโอ
![[Industry Voice #34] Staidson Biopharmaceuticals on Breakthrough Antibody Therapies](http://i.ytimg.com/vi/zoRBBux4oic/mqdefault.jpg)
![[Industry Voice #34] Staidson Biopharmaceuticals on Breakthrough Antibody Therapies](/img/tr.png)
[Industry Voice #34] Staidson Biopharmaceuticals on Breakthrough Antibody Therapies
มุมมอง 1548 หลายเดือนก่อน
0:25 Introduction 0:53 Opportunities in the International Markets 1:54 Current Trends in the Biopharma and Healthcare Industry 3:39 Most Promising Fields of Research 8:14 Outsourced Clinical Trials 8:56 Criteria for Selecting a CRO Welcome to our newest Industry Voice Podcast Series episode. This video is an insightful interview with Lee Smith Adageng from a leading Chinese biopharmaceutical co...
Completion of a Phase 2b Study in Lower Back Pain Despite Hurdles Caused by the Pandemic
มุมมอง 529 หลายเดือนก่อน
A Sweden-based pharmaceutical company #StaybeTherapeutics partnered with OCT Clinical, a leading CRO in Eastern Europe, to run a Phase 2b study in three European countries. This is a multicenter, randomized Phase 2b study, the primary goal of which is to evaluate the efficacy of the study medicine vs. placebo. The study is double-blinded, which means that neither the patient nor the treating ph...
![[Industry Voice #33] Tips for Success in Modern Bioengineering | BioEngine | Vaccines | CGTs](http://i.ytimg.com/vi/fDGRu_DEx8c/mqdefault.jpg)
[Industry Voice #33] Tips for Success in Modern Bioengineering | BioEngine | Vaccines | CGTs
มุมมอง 1619 หลายเดือนก่อน
Are you an emerging biotech company eager to explore new realms of innovation and seize untapped market opportunities? In today's episode of #IndustryVoice Podcast Series, we are here to provide you with insights on this matter. Join us in this episode to find out about the essential factors to consider when striving for success in the dynamic landscape of modern #bioengineering Our guest, Dr. ...
CRO Insights #3 | Clinical Trial Coordinator
มุมมอง 1119 หลายเดือนก่อน
We're back with another episode of our #CROInsights series! In this interview, we talked to Anastasia Aleksandrova, Senior Clinical Trial Coordinator at #OCTClinical, to learn about how important thorough coordination processes can be in clinical trials. Stay tuned for more expert content! Enjoy and subscribe to our TH-cam channel to be the first to know about new content on clinical research. ...
OCT Clinical Interviewed by a Chinese TV Channel
มุมมอง 469 หลายเดือนก่อน
OCT is very much pleased to inform you that Polina Nabieva, our Business Development Manager, recently gave an interview to a Chinese local TV channel at the 14th China International Pharmaceutical Expo in Taizhou. This year's expo had a strong international focus, bringing together pharmaceutical companies from partner countries. With nearly 600 companies participating from 17 different countr...
![[Industry Voice #32] What's Up with Global Life Science Investments? | LSV Capital](http://i.ytimg.com/vi/pO6Wkg6RKwM/mqdefault.jpg)
[Industry Voice #32] What's Up with Global Life Science Investments? | LSV Capital
มุมมอง 17511 หลายเดือนก่อน
Getting back to the world of clinical research with #IndustryVoice! In today's episode, we sit down with Kyla Xue, a managing partner at LSV Capital - a multi-stage investment company from #China. Kyla unveils her perspectives on the criteria for selecting portfolio companies, the importance of innovation in biotech and medtechs, and shares insights on how to finance areas like immunology, neur...
![[Industry Voice #31] JS Bio on How to Diversify R&D Capabilities When Doing Business Internationally](http://i.ytimg.com/vi/Lc3u97xkCdk/mqdefault.jpg)
[Industry Voice #31] JS Bio on How to Diversify R&D Capabilities When Doing Business Internationally
มุมมอง 25611 หลายเดือนก่อน
Welcome to another episode of the #IndustryVoice podcast series, in which we delve into the world of #biopharmaceutical #innovation and global collaborations. This time we sit down with Dr. Luo Shun, the Founder and Chairman of #JSBio, a pioneering cell culture media supplier with a global footprint across the United States and #China. Join us for this conversation as we unravel the intersectio...
![[Industry Voice #30] EmPOWERing Patients Into Clinical Research | Brandon Li](/img/n.gif)
[Industry Voice #30] EmPOWERing Patients Into Clinical Research | Brandon Li
มุมมอง 403ปีที่แล้ว
Welcome to the landmark episode of our #IndustryVoice series! Join us as we discuss the topic of helping patients find and access clinical trials. Our guest, Brandon Li, CEO, and Co-founder of #Power, introduces his revolutionary platform that grants easy access to all currently available clinical trials in North America for patients worldwide. In fact, Power's patient-centric platform helps in...
[Industry Voice #29] QL Biopharm's Vision for the Future of Chronic Metabolic Diseases
มุมมอง 1.3Kปีที่แล้ว
[Industry Voice #29] QL Biopharm's Vision for the Future of Chronic Metabolic Diseases
[Industry Voice #28] Craig Lipset on FDA’s Quotes | Big Pharma Standpoint | DCTs
มุมมอง 318ปีที่แล้ว
[Industry Voice #28] Craig Lipset on FDA’s Quotes | Big Pharma Standpoint | DCTs
[Webinar] E9(R1) Addendum on Estimands: The Use of Estimand Framework for Oncology Clinical Trials
มุมมอง 698ปีที่แล้ว
[Webinar] E9(R1) Addendum on Estimands: The Use of Estimand Framework for Oncology Clinical Trials
CRO Insights #2 | Clinical Trial Project Management
มุมมอง 273ปีที่แล้ว
CRO Insights #2 | Clinical Trial Project Management
[Industry Voice #27] Recbio on International Clinical Trial Project Management
มุมมอง 349ปีที่แล้ว
[Industry Voice #27] Recbio on International Clinical Trial Project Management
[Industry Voice #26] What's Happening to Clinical Trials in Ukraine? A Local CRO's Perspective
มุมมอง 381ปีที่แล้ว
[Industry Voice #26] What's Happening to Clinical Trials in Ukraine? A Local CRO's Perspective
How we completed patient enrolment on time and within budget despite hurdles caused by the pandemic
มุมมอง 131ปีที่แล้ว
How we completed patient enrolment on time and within budget despite hurdles caused by the pandemic
EDC Data Management Solutions by OCT Clinical
มุมมอง 178ปีที่แล้ว
EDC Data Management Solutions by OCT Clinical
CRO Insights #1 | Tips For a Successful Clinical Study Startup
มุมมอง 356ปีที่แล้ว
CRO Insights #1 | Tips For a Successful Clinical Study Startup
[Industry Voice #25] Decentralization or not? Exploring new models of pharma research with Castor
มุมมอง 572ปีที่แล้ว
[Industry Voice #25] Decentralization or not? Exploring new models of pharma research with Castor
[Industry Voice #24] Patient recruitment via Facebook, TikTok, Reddit, Snapchat
มุมมอง 604ปีที่แล้ว
[Industry Voice #24] Patient recruitment via Facebook, TikTok, Reddit, Snapchat
[Industry Voice #23] NKILT Therapeutics on cell and gene therapy: the next wave of pharma innovation
มุมมอง 1Kปีที่แล้ว
[Industry Voice #23] NKILT Therapeutics on cell and gene therapy: the next wave of pharma innovation
[Industry Voice #22] Geropharm: Pharmaceutical Research in 2022| Opportunities & Challenges
มุมมอง 3982 ปีที่แล้ว
[Industry Voice #22] Geropharm: Pharmaceutical Research in 2022| Opportunities & Challenges
[Webinar] Demystifying the Intricacies of Analysis Datasets and ADaM Standard
มุมมอง 1.2K2 ปีที่แล้ว
[Webinar] Demystifying the Intricacies of Analysis Datasets and ADaM Standard
[Industry Voice #21] Vaccine Development Demystified by ACM Biosciences
มุมมอง 4962 ปีที่แล้ว
[Industry Voice #21] Vaccine Development Demystified by ACM Biosciences
[Industry Voice #20] Roche on RWE: shifting the landscape of clinical research and healthcare
มุมมอง 1.7K2 ปีที่แล้ว
[Industry Voice #20] Roche on RWE: shifting the landscape of clinical research and healthcare
[Industry Voice #19] Clinical Research in Africa | Chatbots for ePRO | VR and AI in Clinical Trials
มุมมอง 6612 ปีที่แล้ว
[Industry Voice #19] Clinical Research in Africa | Chatbots for ePRO | VR and AI in Clinical Trials
[Webinar] Master Your Clinical Trial Budget:A Step-by-Step Guide to Smart Clinical Expense Planning
มุมมอง 4.2K2 ปีที่แล้ว
[Webinar] Master Your Clinical Trial Budget:A Step-by-Step Guide to Smart Clinical Expense Planning
[Industry Voice #18] Bayer on the Future of Pharmaceutical Clinical Research
มุมมอง 5242 ปีที่แล้ว
[Industry Voice #18] Bayer on the Future of Pharmaceutical Clinical Research
[Industry Voice #17] BIOCAD On Its Vaccine, In-House Clinical Trials, Post-Pandemic Research
มุมมอง 8442 ปีที่แล้ว
[Industry Voice #17] BIOCAD On Its Vaccine, In-House Clinical Trials, Post-Pandemic Research
Hello Mam, Can I help Your Growing TH-cam Channel?
great podcast! way to go
thank you for the feedback!
Watch the full video here: th-cam.com/video/zoRBBux4oic/w-d-xo.html
Why is SAS used? It’s not open source or generally accessible. R is better.
Hello! Thank you for watching our webinar and your astute comment. We highly appreciate it. SAS had been a solid and validated system and been considered a golden standard in the pharma industry for years. Sponsors used to be less inclined to use an open-code system like R, while regulatory authorities used have doubts and reservations because the system was difficult to validate. But indeed, over the past several years there has been a distinct shift toward more a extended use of R in clinical trials. And in this webinar the speaker neither evaluates nor advocates for SAS as the top choice for clinical trials.
hello ma'am, i am graduate student of pharmacy and right now i am pursuing my masters in regulatory affairs. your video was very insightful and very easy to understand about regulation of clinical approval in Russia as my topic of mid semester is also same which clinical trial approval in Russia. if you don't mind could you please share me this PDF file so that i can use it as reference in my topic. thank you
Watch the full interview here: th-cam.com/video/pO6Wkg6RKwM/w-d-xo.html
Watch the full interview here: th-cam.com/video/Lc3u97xkCdk/w-d-xo.html
Watch the full interview here: th-cam.com/video/s8uuzmubgfw/w-d-xo.html
good stuff
Watch the full interview here: th-cam.com/video/_Wv5Fn-S0YQ/w-d-xo.html
Watch the full interview with Craig here: th-cam.com/video/sQ9KLfQyivY/w-d-xo.html
Watch the full interview here: th-cam.com/video/sr2b-7BnE1s/w-d-xo.html
Watch the full interview here: th-cam.com/video/6J4wz5WjNdw/w-d-xo.html
Watch the full interview here: th-cam.com/video/-d5wBRteTIg/w-d-xo.html
good stuff
good stuff
Yuriy is out-of-the box clinical trials leader
Анечка красавица! Приятно слушать)
Very helpful. Thank you.
You're welcome!
Thank you for this extensive and interesting interview! ^O^
Thank you👏
This is not the platform to fully discuss my plans, but in simplest terms research leads to new developments in pharma.
insightful, thank you! Great speaker
Glad you enjoyed it!
Nice to see Ukraine in list 27.21
Thank you for your comment. Ukraine is indeed one of the global leaders in patient recruitment.
Very interesting and truly inspirational!!! thank you for this interview!
Thank you for your feedback!
Great insights, thanks
Thank you for your feedback!
Норм офис у фармы!!
интересная гость// четко и по делу говорит
С интересом смотрю интервью/ хотелось бы побольше именно про технологии будущего и виар в медицине// и на русском//
Did you like the interview? What topic would you like us to cover next time?
thanks a lot. some uptodate discussions on RWE and real world data would be great
vaccine development
Great topics and a very interesting interviewee!
Thank you for your feedback!
Thank you for the chosen format of the video. It's short enough and easy to watch, and gives a very clear understanding of industry trends👍
Thank you!
Insightful
Очередное интересное интервью. Молодцы Аня и Кристина!
very inspiring, thank you
It was great webinar. Thank you.
We appreciate your feedback, thank you.
Интересное и полезное интервью.
класс!! очень интересно было послушать. инфо по рынку, конкретные примеры, модная тема мед.кластеров и чёткий совет по стратегиям входа на Россию. супер спикер, супер модератор. профессиональный ролик, смотрела, как тэд😀🔥
Интересное интервью. Жаль только, что камера не передает всего обаяния Романа ))
Люблю слушать профессионалов своего дела!
Looking forward to seeing the final results
Интересно!